Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer

BACKGROUND: Survival from gastric cancer remains poor, particularly in Western populations. Previous pre-clinical and subgroup analyses of clinical trials have suggested differing benefits from fluoropyrimidine-based chemotherapeutics for diffuse and intestinal gastric cancer. This analysis examines...

Descripción completa

Detalles Bibliográficos
Autores principales: Pattison, Sharon, Mitchell, Catherine, Lade, Stephen, Leong, Trevor, Busuttil, Rita A., Boussioutas, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602536/
https://www.ncbi.nlm.nih.gov/pubmed/28922362
http://dx.doi.org/10.1371/journal.pone.0183891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602536/
https://www.ncbi.nlm.nih.gov/pubmed/28922362
http://dx.doi.org/10.1371/journal.pone.0183891

Ejemplares similares